Kingsview Wealth Management LLC Invests $2.55 Million in Astera Labs, Inc. $ALAB

Kingsview Wealth Management LLC bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 5,285 shares of the company’s stock, valued at approximately $2,553,000.

A number of other institutional investors and hedge funds have also made changes to their positions in ALAB. Glenmede Trust Co. NA raised its holdings in Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after purchasing an additional 51 shares in the last quarter. Keating Financial Advisory Services Inc. purchased a new stake in Astera Labs in the 2nd quarter valued at approximately $25,000. Lido Advisors LLC boosted its holdings in Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares in the last quarter. Transamerica Financial Advisors LLC purchased a new stake in Astera Labs in the 2nd quarter valued at approximately $35,000. Finally, Goldstein Advisors LLC increased its position in Astera Labs by 5.8% during the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock worth $268,000 after purchasing an additional 88 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently issued reports on ALAB. Citigroup reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. Royal Bank Of Canada lifted their price target on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Jefferies Financial Group upped their price objective on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Astera Labs in a research report on Tuesday, August 18th. Finally, Zacks Research raised Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and an average price target of $340.53.

Insider Buying and Selling at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total value of $4,047,300.00. Following the sale, the director directly owned 4,631 shares in the company, valued at $2,083,950. The trade was a 66.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares in the company, valued at $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 419,244 shares of company stock worth $163,135,169. Insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

NASDAQ ALAB opened at $289.47 on Friday. The business has a 50 day moving average price of $342.38 and a 200 day moving average price of $249.65. The company has a market capitalization of $50.22 billion, a P/E ratio of 143.30 and a beta of 3.84. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.Astera Labs’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.